Andere Sprachen Venus Concept Inc.

Aktien

A3EEV0

US92332W2044

VERO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 01.05.2024			% 5 Tage	% 1. Jan.
0,6667 ^USD	+1,10 %		-7,52 %	-43,50 %

08.04.	Venus Concept Inc. kündigt israelische Zulassung für Venus Bliss MAX an	CI
01.04.	Transcript : Venus Concept Inc., Q4 2023 Earnings Call, Apr 01, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing	24.04.
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024	15.04.
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX	08.04.
Venus Concept Inc. Announces Israeli Regulatory Approval for Venus Bliss MAX	08.04.
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro	03.04.
Venus Concept Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Venus Concept: Q4 Earnings Snapshot	01.04.
Venus Concept Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01.04.
Earnings Flash (VERO) VENUS CONCEPT Posts Q4 Revenue $18.1M	01.04.
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results	01.04.
Venus Concept Inc. Provides Earning Guidance for the Three Months Ended March 31, 2024	01.04.
Venus Concept Continues Listing on Nasdaq, Gets May Deadline to Meet Equity Requirement	25.03.
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules	25.03.
Certain Options of Venus Concept Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13.03.
Venus Concept Launches “NEXThetics” Program	12.03.
Venus Concept Inc. announced that it has received CAD 1.095782 million in funding	07.03.
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB	28.02.
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28.02.
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	27.02.
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Venus Concept Inc.

Aktien

A3EEV0

US92332W2044

VERO

Andere Sprachen

Filter